MedReleaf Corp. (TSE:LEAF) had its price target increased by equities research analysts at Canaccord Genuity from C$15.00 to C$20.00 in a note issued to investors on Tuesday. Canaccord Genuity’s price objective points to a potential upside of 9.59% from the stock’s previous close.
MedReleaf Corp. (TSE:LEAF) traded up C$1.10 during trading on Tuesday, reaching C$18.25. 896,924 shares of the company’s stock traded hands, compared to its average volume of 150,979. MedReleaf Corp. has a 1 year low of C$6.81 and a 1 year high of C$18.90.
In other MedReleaf Corp. news, insider Stephen Arbib sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of C$8.10, for a total value of C$81,000.00.
About MedReleaf Corp.
Receive News & Ratings for MedReleaf Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedReleaf Corp. and related companies with MarketBeat.com's FREE daily email newsletter.